NCT05615506

Brief Summary

The aim of this prospective study is to evaluate the efficacy and safety of endoscopic suction diathermy adenoidectomy as regard the operative time, adenoid tissue remnant, blood loss, and clinical events like pain, halitosis, postoperative hemorrhage, speech changes and recurrence.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 12, 2022

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

October 25, 2022

Completed
20 days until next milestone

First Posted

Study publicly available on registry

November 14, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2023

Completed
Last Updated

December 1, 2022

Status Verified

November 1, 2022

Enrollment Period

6 months

First QC Date

October 25, 2022

Last Update Submit

November 29, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • the efficacy of suction diathermy in completeness of adenoid removal

    Flexible fibre optic nasopharyngoscope or zero degree nasal endoscope is used for evaluation of the nasopharynx and determine the adenoid remnant in percentage.

    intraoperative

  • amount of intraoperative blood loss with suction diathermy adenoidectomy

    amount of blood loss measured in cubic centimeter

    intraoperative

  • Recurrence of symptoms

    Flexible fibre optic nasopharyngoscope or 0 degree nasal endoscope is used for evaluation of the nasopharynx to detect any remnant or recurrence of adenoid in percentage

    6 months

  • postoperative hemorrhage

    percentage of occurence of post operative hemorrhage

    2 weeks

Secondary Outcomes (5)

  • Intraoperative trauma to adjacent structures with suction diathermy adenoidectomy

    6 months

  • Postoperative pain

    7 days

  • postoperative halitosis

    7 days

  • operative time with suction diathermy adenoidectomy

    6 months

  • Speech changes

    6 months

Study Arms (1)

patients

EXPERIMENTAL

suction diathermy adenoidectomy

Procedure: Suction Diathermy Adenoidectomy

Interventions

suction diathermy adenoidectomy

patients

Eligibility Criteria

AgeUp to 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Obstructive symptoms such as long-lasting nocturnal snoring, sleep apnea, and open mouth breathing, bilateral nasal obstruction, and/or bilateral nasal discharge.
  • Adenoid hypertrophy is the only cause of nasal obstruction.
  • Radiography evidence of adenoid hypertrophy encroaching on the airway column.
  • Age under 15 years.
  • Sex: both males and females.
  • All patients are generally well and fit for surgery.

You may not qualify if:

  • Presence of chronic diseases such as chronic heart diseases, chronic liver diseases, chronic renal diseases, and diabetes mellitus.
  • Patients with other causes of nasal obstruction such as acute rhinitis, allergic rhinitis, septal deviation, inferior turbinate hypertrophy, antrochoanal polyp, nasal polypi or anatomical deformities (Choanal atresia).
  • Cases with submucous cleft palate and cases with a previous history of cleft palate repair.
  • Patients with bleeding or coagulation defects.
  • Patients with atrophic rhinitis.
  • Patients with recurrent adenoid.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Amr Hamed Hashem

Sohag, Egypt

RECRUITING

Related Publications (8)

  • Gates GA, Muntz HR, Gaylis B. Adenoidectomy and otitis media. Ann Otol Rhinol Laryngol Suppl. 1992 Jan;155:24-32. doi: 10.1177/00034894921010s106.

  • Dinis PB, Haider H, Gomes A. The effects of adenoid hypertrophy and subsequent adenoidectomy on pediatric nasal airway resistance. Am J Rhinol. 1999 Sep-Oct;13(5):363-9. doi: 10.2500/105065899781367564.

  • Clemens J, McMurray JS, Willging JP. Electrocautery versus curette adenoidectomy: comparison of postoperative results. Int J Pediatr Otorhinolaryngol. 1998 Mar 1;43(2):115-22. doi: 10.1016/s0165-5876(97)00159-6.

  • Shapiro NL, Bhattacharyya N. Cold dissection versus coblation-assisted adenotonsillectomy in children. Laryngoscope. 2007 Mar;117(3):406-10. doi: 10.1097/MLG.0b013e31802ffe47.

  • Pagella F, Pusateri A, Canzi P, Caputo M, Marseglia A, Pelizzo G, Matti E. The evolution of the adenoidectomy: analysis of different power-assisted techniques. Int J Immunopathol Pharmacol. 2011 Oct;24(4 Suppl):55-9. doi: 10.1177/03946320110240S411.

  • Wright ED, Manoukian JJ, Shapiro RS. Ablative adenoidectomy: a new technique using simultaneous liquefaction/aspiration. J Otolaryngol. 1997 Feb;26(1):36-43.

  • Regmi D, Mathur NN, Bhattarai M. Rigid endoscopic evaluation of conventional curettage adenoidectomy. J Laryngol Otol. 2011 Jan;125(1):53-8. doi: 10.1017/S0022215110002100. Epub 2010 Oct 18.

  • Agrawal V, Agarwal PK, Agrawal A. Defining the Surgical Limits of Adenoidectomy so as to Prevent Recurrence of Adenoids. Indian J Otolaryngol Head Neck Surg. 2016 Jun;68(2):131-4. doi: 10.1007/s12070-016-0971-7. Epub 2016 Mar 12.

Central Study Contacts

amr h elsherif, resident

CONTACT

elhussein a ali, a.professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: patients under 15 years old who are scheduled to undergo elective adenoidectomy with or without ventilation tube application. , selected randomly, with symptoms and signs suggestive of adenoid hypertrophy.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

October 25, 2022

First Posted

November 14, 2022

Study Start

October 12, 2022

Primary Completion

April 1, 2023

Study Completion

October 1, 2023

Last Updated

December 1, 2022

Record last verified: 2022-11

Locations